Abstract

The HUSH complex represses retroviruses, transposons and genes to maintain the integrity of vertebrate genomes. HUSH regulates deposition of the epigenetic mark H3K9me3, but how its three core subunits — TASOR, MPP8 and Periphilin — contribute to assembly and targeting of the complex remains unknown. Here, we define the biochemical basis of HUSH assembly and find that its modular architecture resembles the yeast RNA-induced transcriptional silencing complex. TASOR, the central HUSH subunit, associates with RNA processing components. TASOR is required for H3K9me3 deposition over LINE-1 repeats and repetitive exons in transcribed genes. In the context of previous studies, this suggests that an RNA intermediate is important for HUSH activity. We dissect the TASOR and MPP8 domains necessary for transgene repression. Structure-function analyses reveal TASOR bears a catalytically-inactive PARP domain necessary for targeted H3K9me3 deposition. We conclude that TASOR is a multifunctional pseudo-PARP that directs HUSH assembly and epigenetic regulation of repetitive genomic targets.

The HUSH complex plays a key role in controlling transcription of viruses and transposable elements. Here, the authors define the biochemical basis of HUSH assembly and show that the TASOR subunit contains a pseudo-PARP domain critical for HUSH-dependent transgene repression and H3K9me3 deposition over targets genome wide.

Details

Title
TASOR is a pseudo-PARP that directs HUSH complex assembly and epigenetic transposon control
Author
Douse, Christopher H 1   VIAFID ORCID Logo  ; Tchasovnikarova, Iva A 2 ; Timms, Richard T 3   VIAFID ORCID Logo  ; Protasio, Anna V 4   VIAFID ORCID Logo  ; Seczynska Marta 3 ; Prigozhin, Daniil M 5   VIAFID ORCID Logo  ; Albecka Anna 6 ; Wagstaff, Jane 7 ; Williamson, James C 3 ; Freund, Stefan M, V 7 ; Lehner, Paul J 3   VIAFID ORCID Logo  ; Modis Yorgo 8   VIAFID ORCID Logo 

 University of Cambridge, MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Molecular Immunity Unit, Department of Medicine, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); Lund University, Department of Experimental Medical Science, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361) 
 University of Cambridge School of Clinical Medicine, Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); The Gurdon Institute, Cambridge, UK (GRID:grid.450000.1) (ISNI:0000 0004 0606 5024) 
 University of Cambridge School of Clinical Medicine, Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
 University of Cambridge School of Clinical Medicine, Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); Department of Pathology, University of Cambridge, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
 University of Cambridge, MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Molecular Immunity Unit, Department of Medicine, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); Lawrence Berkeley National Laboratory, Molecular Biophysics and Integrated Bioimaging Division, Berkeley, USA (GRID:grid.184769.5) (ISNI:0000 0001 2231 4551) 
 University of Cambridge, MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Molecular Immunity Unit, Department of Medicine, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); University of Cambridge School of Clinical Medicine, Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); MRC Laboratory of Molecular Biology, Cambridge, UK (GRID:grid.42475.30) (ISNI:0000 0004 0605 769X) 
 Structural Studies Division, MRC Laboratory of Molecular Biology, Cambridge, UK (GRID:grid.42475.30) (ISNI:0000 0004 0605 769X) 
 University of Cambridge, MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Molecular Immunity Unit, Department of Medicine, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); University of Cambridge School of Clinical Medicine, Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2449451576
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.